Objective. To assess the seroprevalence of immunity to the rubella virus in pregnant women in Haiti attending the Obstetrics and Gynecology Department of the
temic disease that can be prevented by vaccination during infancy and adolescence (2) . The Pan American Health Organization (PAHO) has encouraged the countries of the Western Hemisphere to include the vaccine in their vaccination programs (3, 4) . Cuba and the islands of the English-speaking Caribbean have progressed in controlling this transmissible disease because of aggressive vaccination programs (3, 5) . Nevertheless, Haiti is among the very few countries in the Region of the Americas without a vaccination program against rubella.
In Haiti a recent confirmed case of congenital rubella syndrome at the State University Hospital in Port-auPrince focused our attention on the severity and the underestimation of this problem in the country. Recent estimates put the incidence of new cases of CRS in Haiti at between 163 and 440 per 100 000 live births per year. That rate is high in comparison to the incidences of CRS that Jamaica, Trinidad, and the United States of America had in their prevaccination years (6) . This is the first study of seroprevalence of rubella in pregnant women in Haiti. Because of the high illiteracy rate in Haiti, an informed consent form was read aloud to each of the participants in Haitian Creole, the language spoken by all the people in the country. After asking and receiving answers to any questions she had, the woman indicated her consent by signing the form. A 2.5-mL blood sample was drawn and then sent the same day to the Virology Laboratory of the State University Hospital. The sera were separated and stored at -20 °C until tested for rubella.
METHODS

This is
Rubella-specific immunoglobulin G (IgG) antibodies were screened quantitatively using commercial enzyme immunoassay kits (Dade Behring, Marburg, Germany). Rubella IgG titers of 15 International Units/mL or greater were considered positive. For quality control testing, 40 sera were randomly selected and sent to the PAHO/ World Health Organization Caribbean Regional Epidemiological Center (CAREC) on the island of Trinidad. All the CAREC results matched the ones found at the State University Hospital Virology Laboratory.
The chi-square test was used to determine the statistical significance of any difference in the rates of rubella seronegativity (susceptibility) of pregnant women residing in Port-au-Prince and of pregnant women residing in rural areas of the country. A P value of < 0.05 was considered statistically significant.
RESULTS
From the total of 495 pregnant women tested and included in our analysis, 471 of them were seropositive (95.2%), and 24 were seronegative (4.8%). In terms of age, 81 of the 495 women (16.4% of them) were less than 21 years old, 402 of them (81.2%) were between the ages of 21 and 40, and 12 of them (2.4%) were 41-45 years old. As mentioned above, 426 of the 495 women were living in Port-au-Prince or the surrounding metropolitan area, and the other 69 patients were from rural regions of Haiti. Of the 69 women from the rural areas, 7 of them (10.1%) tested seronegative, compared with 17 of the 426 women (4.0%) living in the capital city ( Table 1 ). The difference was statistically significant (P = 0.02). Among the 24 seronegative women, 15 of them (62.5%) were less than 31 years old, that is, in their prime reproductive years.
DISCUSSION
Even with an overall low susceptibility (seronegativity) rate of 4.8%, congenital rubella syndrome could still occur in Haiti. That happened, for ex- ample, in one region of Oman where only 4% of the women were susceptible (7, 8) . Because our study population consisted of women who were attending the prenatal clinic or had come to give birth at the State University Hospital, a selection bias could be responsible for the 95.2% seropositivity rate that we found. Nevertheless, the relatively high cost of the rubella vaccine for the average Haitian and the low socioeconomic status of our patients made it very unlikely that they had received the vaccine. Rubella vaccine is given on a very limited basis by private practitioners in Port-au-Prince, and it is not included in the Expanded Program on Immunization of the Ministry of Health of Haiti. Indeed, information about any previous rubella immunizations of the women participating in the study was so unreliable that we researchers did not take it into account. A more realistic explanation for the 95.2% seropositivity of the pregnant women in the study is the widespread circulation of the rubella virus in the general population in Haiti.
Many countries in the developing world have reported relatively low rubella susceptibility rates compared to those for industrialized countries in their prevaccination periods (7). Earlier rubella outbreaks in Guyana and in Jamaica are proof of rubella virus circulation in the Caribbean area (2, 9) . On the other hand, most of the women whom we tested live in crowded urban areas, where circulation of the rubella virus is easier than in rural areas. Studies done in Panama and Peru have found marked differences in estimates of rubella infection in urban and rural areas (10) .
We found a statistically significant difference in the rate of seronegativity for rubella virus between the women residing in Port-au-Prince and those living in rural areas. Because of the low overall seronegativity, rubella vaccination efforts targeting children under 15 years old would be a less costly strategy for preventing CRS than would vaccinating large segments of the population, including women up to 45 years old.
We recommend additional research using randomized sampling and including a significant proportion of women from rural areas. Even with the limitations with the data that we collected, our study is an important first step in addressing the issue of seroprevalence of rubella virus antibodies in Haitian women and in dealing with the still-underrecognized public health problem of congenital rubella syndrome in the country.
Objetivo. Determinar la seroprevalencia de la inmunidad al virus de la rubéola en mujeres embarazadas que se atienden al Departamento de Obstetricia y Ginecología del Hospital de la Universidad Estatal, en Puerto Príncipe, capital de Haití, a fin de contribuir a introducir la vacunación de la población contra la rubéola y proteger a las mujeres en edad reproductiva en el país. Métodos. Este estudio transversal se realizó entre febrero y mayo de 2002. Se evaluó la presencia de anticuerpos de tipo IgG específicos contra la rubéola en 503 embarazadas mediante un inmunoensayo enzimático. Posteriormente se excluyó a 8 mujeres debido a que no sabían su edad. Resultados. De las 495 participantes estudiadas, 471 (95,2%) tenían seropositividad; solo 24 de ellas (4,8%) mostraron seronegatividad (susceptibilidad). Se encontraron menos mujeres seronegativas entre las residentes de Puerto Príncipe (17 de 426, 4,0%) que entre las residentes de zonas rurales (7 de 69, 10,1%) (P = 0,02). En relación con la edad, 81 (16,4%) de las 495 mujeres embarazadas estudiadas eran menores de 21 años. Conclusiones. Con este estudio se da el primer paso hacia evaluar la prevalencia de la infección por el virus de la rubéola en mujeres haitianas y hacia el enfrentamiento de un problema de salud que todavía no ha sido reconocido en toda su magnitud: el síndrome de la rubéola congénita en Haití. Se recomienda emprender estudios adicionales con muestreos aleatorios que abarquen una fracción significativa de mujeres provenientes de zonas rurales.
RESUMEN
Seroprevalencia de anticuerpos contra el virus
de la rubéola en mujeres embarazadas de Haití
